CA_125_regression:_a_model_for_epithelial_ovarian_cancer_response._The_rate_of_decline_of_CA_125_in_effectively_treated_epithelial_ovarian_cancer_is_described_by_the_exponential_regression_curve_CA_125_=_EXP_i_-_s_(days_after_surgery)._In_this_equation_i,_the_y-axis_intercept,_measures_initial_tumor_burden_whereas_s,_the_slope_of_the_regression_curve,_is_determined_by_the_extent_of_cytoreductive_surgery_and_the_subsequent_response_to_chemotherapy._Departure_from_the_regression_curve_uniformly_results_in_progressive_disease._In_patients_whose_cancers_had_been_completely_removed,_we_calculated_the_mean_half-life_of_CA_125_to_be_10.4_days_(range_4_to_21)._In_this_case_s_=_0.0835_and_characterizes_the_ideal_regression_rate._The_model_predicts_that_high-dose_cisplatin_chemotherapy_(s_=_0.0671)_is_more_effective_than_low-dose_cisplatin_(s_=_0.0380)_(p_less_than_0.03)_in_eliminating_residual_cancer._Because_s_can_be_calculated_within_2_to_3_months_of_treatment_and_then_compared_with_s_for_the_ideal_regression_curve_and_with_the_values_of_s_reported_for_standard_chemotherapy,_evaluation_of_any_new_treatment_protocol_can_be_facilitated_with_this_method.